Literature DB >> 8255106

Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia.

H Ohno1, S Doi, K Yabumoto, S Fukuhara, T W McKeithan.   

Abstract

The t(14;19)(q32;q13) is a recurring translocation found in leukemic cells of some patients with chronic lymphocytic leukemia (CLL). The BCL3 gene was identified on chromosome 19 adjacent to the breakpoint of the translocation, and has been proposed to be a candidate proto-oncogene which may play a role in leukemogenesis. The current study of a Japanese patient with CLL revealed that the (14;19) is reciprocal at the molecular level; the BCL3 gene was juxtaposed to the 5' side of the S alpha 1 switch region of the immunoglobulin heavy chain gene (IGH) on the der(14) chromosome, and the IGH gene 5' to the S alpha 1 region was joined to chromosome 19 sequences on the der(19) reciprocal partner chromosome. The breakpoint on chromosome 19 was 16 kb upstream of the first exon of the BCL3 gene and 7 bp of chromosome 19 sequences were deleted at the point of the junction. The t(14;19) translocations so far molecularly analyzed consistently occurred within one of the two S alpha switch regions; however, sequence analysis of the chromosome 19 regions involved in the translocation failed to demonstrate an obvious sequence similarity with the switch region. The chromosomal breaks on chromosome 19 from two CLL patients having the t(14;19) were within Alu repeated sequences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255106

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition.

Authors:  S D Westerheide; M W Mayo; V Anest; J L Hanson; A S Baldwin
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 3.  Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma.

Authors:  Hitoshi Ohno; Momoko Nishikori; Yoshitomo Maesako; Hironori Haga
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

4.  Trans-chromosomal recombination within the Ig heavy chain switch region in B lymphocytes.

Authors:  M Kingzette; H Spieker-Polet; P C Yam; S K Zhai; K L Knight
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

5.  Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.

Authors:  Francesca Micci; Ioannis Panagopoulos; Geir E Tjønnfjord; Arne Kolstad; Jan Delabie; Klaus Beiske; Sverre Heim
Journal:  Virchows Arch       Date:  2007-04-04       Impact factor: 4.064

6.  Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity.

Authors:  Vivien Ya-Fan Wang; Yidan Li; Daniel Kim; Xiangyang Zhong; Qian Du; Majid Ghassemian; Gourisankar Ghosh
Journal:  Mol Cell       Date:  2017-07-06       Impact factor: 17.970

7.  The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.

Authors:  Xiaoren Zhang; Andrea Paun; Estefania Claudio; Hongshan Wang; Ulrich Siebenlist
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.422

8.  Atypical IκB Bcl3 enhances the generation of the NF-κB p52 homodimer.

Authors:  Wenfei Pan; Limei Deng; Haitao Wang; Vivien Ya-Fan Wang
Journal:  Front Cell Dev Biol       Date:  2022-08-05

9.  BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.

Authors:  Yuna Niu; Xue Yang; Yifei Chen; Linbo Zhang; Xinyue Jin; Youjing Tang; Li Li; Lu Yu; Yilin Guo; Hui Wang
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.